WEST CONSHOHOCKEN, Pa., Sept. 28, 2021 /PRNewswire/ — BTG Specialty Pharmaceuticals announced that Ohara Pharmaceutical Co., Ltd. has obtained marketing authorization for glucarpidase from Japan ...

Pharmaceutical firm BTG (BTG.L) upgraded its sales forecast on Thursday after it included its varicose vein treatment Varithena in its oncology and vascular portfolio and saw strong demand for its ...

BTG Pharmaceuticals provides antidotes that counteract the potentially life-threatening effects associated with exposure or overexposure to certain toxins.

SOMERSET, N.J., Oct. 25, 2010 (GLOBE NEWSWIRE) -- inVentiv Commercial, a division of inVentiv Health and the industry leader in outsourced sales teams to the pharmaceutical industry, announced ...

One company value investors might notice is B2Gold Corp (BTG). BTG is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. The stock is trading with P/E ratio of 11.54 right now.

--BTG Specialty Pharmaceuticals, a division of Boston Scientific, today announced the European Medicines Agency has accepted for review a Marketing Authorisation Application for Voraxaze ®. BTG ...

Boston Scientific Corp. said Tuesday it is selling its BTG Specialty Pharmaceuticals business to Stark International Lux S.A.R.L. and SERB SAS, both affiliates of specialty pharma group SERB, for ...

West Conshohocken, PA, Sept. 21, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, announced today that SERB will present in vivo data for PR022, a polyclonal antibody in development ...

Boston Scientific Corporation has agreed to sell BTG's specialty pharmaceuticals business for $800 million.

Brasil Pharma SA, the Brazilian drugstore chain backed by embattled investment bank Grupo BTG Pactual SA, is going ahead with a plan to raise as much as 600 million reais ($160 million) from ...